Misplaced Fears Leave Pregnant Subjects Out Of Drug Trials
With federal drug regulators set to release new guidance meant to diversify clinical trial populations, new research largely undermines one key rationale for omitting pregnant and lactating people from drug and...To view the full article, register now.
Already a subscriber? Click here to view full article